BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16806200)

  • 1. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
    Salvi M; Sarno S; Marin O; Meggio F; Itarte E; Pinna LA
    FEBS Lett; 2006 Jul; 580(16):3948-52. PubMed ID: 16806200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase CK2 interacts with the splicing factor hPrp3p.
    Lehnert S; Götz C; Kartarius S; Schäfer B; Montenarh M
    Oncogene; 2008 Apr; 27(17):2390-400. PubMed ID: 18026141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effect and its kinetic analysis of baicalein on recombinant human protein kinase CK2 holoenzyme].
    Lin XC; Liu XG; Chen XW; Chen WZ; Liang NC
    Ai Zheng; 2004 Aug; 23(8):874-8. PubMed ID: 15301706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide.
    Poletto G; Vilardell J; Marin O; Pagano MA; Cozza G; Sarno S; Falqués A; Itarte E; Pinna LA; Meggio F
    Biochemistry; 2008 Aug; 47(32):8317-25. PubMed ID: 18636746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promiscuous subunit interactions: a possible mechanism for the regulation of protein kinase CK2.
    Allende CC; Allende JE
    J Cell Biochem Suppl; 1998; 30-31():129-36. PubMed ID: 9893264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for protein kinase CK2 in cell proliferation: evidence using a kinase-inactive mutant of CK2 catalytic subunit alpha.
    Lebrin F; Chambaz EM; Bianchini L
    Oncogene; 2001 Apr; 20(16):2010-22. PubMed ID: 11360185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activity.
    Llorens F; Roher N; Miró FA; Sarno S; Ruiz FX; Meggio F; Plana M; Pinna LA; Itarte E
    Biochem J; 2003 Nov; 375(Pt 3):623-31. PubMed ID: 12901717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction sites between catalytic and regulatory subunits in human protein kinase CK2 holoenzymes as indicated by chemical cross-linking and immunological investigations.
    Krehan A; Lorenz P; Plana-Coll M; Pyerin W
    Biochemistry; 1996 Apr; 35(15):4966-75. PubMed ID: 8664289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How druggable is protein kinase CK2?
    Cozza G; Bortolato A; Moro S
    Med Res Rev; 2010 May; 30(3):419-62. PubMed ID: 19526464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of protein kinase CK2 as oncological target.
    Seeber S; Issinger OG; Holm T; Kristensen LP; Guerra B
    Apoptosis; 2005 Aug; 10(4):875-85. PubMed ID: 16133877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
    Vilk G; Weber JE; Turowec JP; Duncan JS; Wu C; Derksen DR; Zien P; Sarno S; Donella-Deana A; Lajoie G; Pinna LA; Li SS; Litchfield DW
    Cell Signal; 2008 Nov; 20(11):1942-51. PubMed ID: 18662771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effect of lysine-rich polypeptides on the activity of protein kinase CK2.
    Romero-Oliva F; Jacob G; Allende JE
    J Cell Biochem; 2003 May; 89(2):348-55. PubMed ID: 12704797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and localization of epitope-tagged protein kinase CK2.
    Penner CG; Wang Z; Litchfield DW
    J Cell Biochem; 1997 Mar; 64(4):525-37. PubMed ID: 9093902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast holoenzyme of protein kinase CK2 requires both beta and beta' regulatory subunits for its activity.
    Kubiński K; Domańska K; Sajnaga E; Mazur E; Zieliński R; Szyszka R
    Mol Cell Biochem; 2007 Jan; 295(1-2):229-36. PubMed ID: 16933028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of thymidylate synthase from various sources by human protein kinase CK2 and its catalytic subunits.
    Fraczyk T; Kubiński K; Masłyk M; Cieśla J; Hellman U; Shugar D; Rode W
    Bioorg Chem; 2010 Jun; 38(3):124-31. PubMed ID: 20199796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of mitoxantrone on the activity of human protein kinase CK2 holoenzyme].
    Li CM; Liu XG; Lin XC; Chen XW; Liang NC
    Ai Zheng; 2008 Aug; 27(8):809-15. PubMed ID: 18710613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel protein kinase CK2 substrate indicates CK2 is not directly stimulated by polyamines in vivo.
    Lawson K; Larentowicz L; Artim S; Hayes CS; Gilmour SK
    Biochemistry; 2006 Feb; 45(5):1499-510. PubMed ID: 16445292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein kinase CK2(Andante) holoenzyme structure supports proposed models of autoregulation and trans-autophosphorylation.
    Schnitzler A; Olsen BB; Issinger OG; Niefind K
    J Mol Biol; 2014 May; 426(9):1871-82. PubMed ID: 24594356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of plant-specific N-terminal domain of maize CK2β1 subunit in CK2β functions and holoenzyme regulation.
    Riera M; Irar S; Vélez-Bermúdez IC; Carretero-Paulet L; Lumbreras V; Pagès M
    PLoS One; 2011; 6(7):e21909. PubMed ID: 21789193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.